Eagan, United States
Stimdia Medical, headquartered in Minneapolis, MN, is pioneering advancements in respiratory care with its innovative solution, the pdSTIMTM System. This breakthrough device, recognized by the FDA for its potential impact, offers a minimally invasive method to address the muscle atrophy challenges associated with prolonged mechanical ventilation. By reactivating the diaphragm's integrity through neuromuscular stimulation, it promises to facilitate patients' recovery towards autonomous breathing.
Founded in 2015, Stimdia Medical operates within the sectors of Health Care, Health and Wellness, and Medical Devices. Despite its compelling proposition, the pdSTIM System is not yet approved for market sale. The company's latest financial milestone, a $16.00M Series B investment in July 2022, was backed by noted investors like Solas BioVentures and Draper Triangle. As Stimdia Medical progresses towards commercialization, it represents a promising opportunity for investors seeking to support impactful medical technologies.
